Establishing the molecular basis for MDA5 mutation-linked autoimmunity.
5 affiliations
- 1Department of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, CT 06511, United States.
- 2Howard Hughes Medical Institute, Chevy Chase, MD 20815, United States.
- 3Department of Chemistry, The Wertheim UF Scripps Institute, Jupiter, FL 33458, United States.
- 4Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06511, United States.
- 5Department of Chemistry, Yale University, New Haven, CT 06511, United States.
Abstract
Melanoma differentiation-associated protein 5 (MDA5), a member of the RIG-I-like receptor family, is a cytoplasmic sensor essential for innate antiviral immunity. MDA5 distinguishes viral RNA from host RNA in part through its ATP hydrolysis activity, which promotes filament turnover on shorter endogenous double-stranded RNAs (dsRNAs). Here, we show that the gain-of-function T331I disease-linked mutation within the ATP-binding pocket disrupts this balance, resulting in constitutive interferon signaling. Through a combination of cryo-electron microscopy (cryoEM), biochemical assays, and cellular analyses, we reveal the extensive network of interactions that precisely position ATP for catalysis in the wild-type MDA5 ATP-binding pocket and also demonstrate that the T331I mutation impairs ATPase activity, thereby stabilizing MDA5-dsRNA complexes and leading to aberrant immune activation. These findings elucidate how MDA5 ATPase activity regulates antiviral specificity and prevents autoimmunity by controlling filament stability and downstream signaling, offering a mechanistic molecular explanation for disease pathogenesis.
Related
- X-linked hyper IgM syndrome with a novel CD40-ligand gene mutation suffered from infection of Talaromyces marneffei
- ALS-linked FUS mutation impairs GEMIN5-dependent mRNA recruitment to neuronal late endosomes
- A mutation-agnostic and allele-specific ASO strategy demonstrates potent functional rescue and retinal preservation in RHO-linked retinitis pigmentosa
- A novel CD40LG frameshift mutation in an Iranian family with X-linked hyper-IgM syndrome: A case report
- Establishing an ex vivo platform for molecular profiling of skin structural cells using frozen human skin biopsies
BibTeX
@article{xu2026establishing,
title = {{Establishing the molecular basis for MDA5 mutation-linked autoimmunity.}},
author = {Ling Xu and Harim Jang and Kevin Chung and Rong Guo and Alisia Pan and Anna Marie Pyle},
journal = {Nucleic acids research},
year = {2026},
month = sep,
doi = {10.1093/nar/gkag941},
url = {https://europepmc.org/article/MED/42847245},
note = {CC BY},
}
RIS
TY - JOUR
TI - Establishing the molecular basis for MDA5 mutation-linked autoimmunity.
AU - Ling Xu
AU - Harim Jang
AU - Kevin Chung
AU - Rong Guo
AU - Alisia Pan
AU - Anna Marie Pyle
PY - 2026
DA - 2026/09/01
JO - Nucleic acids research
DO - 10.1093/nar/gkag941
UR - https://europepmc.org/article/MED/42847245
AB - Melanoma differentiation-associated protein 5 (MDA5), a member of the RIG-I-like receptor family, is a cytoplasmic sensor essential for innate antiviral immunity. MDA5 distinguishes viral RNA from host RNA in part through its ATP hydrolysis activity, which promotes filament turnover on shorter endogenous double-stranded RNAs (dsRNAs). Here, we show that the gain-of-function T331I disease-linked mutation within the ATP-binding pocket disrupts this balance, resulting in constitutive interferon signaling. Through a combination of cryo-electron microscopy (cryoEM), biochemical assays, and cellular analyses, we reveal the extensive network of interactions that precisely position ATP for catalysis in the wild-type MDA5 ATP-binding pocket and also demonstrate that the T331I mutation impairs ATPase activity, thereby stabilizing MDA5-dsRNA complexes and leading to aberrant immune activation. These findings elucidate how MDA5 ATPase activity regulates antiviral specificity and prevents autoimmunity by controlling filament stability and downstream signaling, offering a mechanistic molecular explanation for disease pathogenesis.
SN - 0305-1048
SN - 1362-4962
ER -